Skip to main content
Top
Published in: Respiratory Research 1/2012

Open Access 01-12-2012 | Commentary

The dendritic cell niche in chronic obstructive pulmonary disease

Author: Angela Haczku

Published in: Respiratory Research | Issue 1/2012

Login to get access

Abstract

The pulmonary innate immune system is heavily implicated in the perpetual airway inflammation and impaired host defense characterizing Chronic Obstructive Pulmonary Disease (COPD). The airways of patients suffering from COPD are infiltrated by various immune and inflammatory cells including macrophages, neutrophils, T lymphocytes, and dendritic cells. While the role of macrophages, neutrophils and T lymphocytes is well characterized, the contribution of dendritic cells to COPD pathogenesis is still the subject of emerging research. A paper by Botelho and colleagues in the current issue of Respiratory Research investigates the importance of dendritic cell recruitment in cigarette-smoke induced acute and chronic inflammation in mice. Dendritic cells of the healthy lung parenchyma and airways perform an important sentinel function and regulate immune homeostasis. During inflammatory responses the function and migration pattern of these cells is dramatically altered but the underlying mechanisms are incompletely understood. Botelho and colleagues demonstrate here the importance of IL-1R1/IL-1α related mechanisms including CCL20 production in cigarette-smoke induced recruitment of dendritic cells and T cell activation in the mouse lung.
Literature
1.
go back to reference Brusselle GG, Joos GF, Bracke KR: New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011, 378: 1015-1026. 10.1016/S0140-6736(11)60988-4.PubMedCrossRef Brusselle GG, Joos GF, Bracke KR: New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011, 378: 1015-1026. 10.1016/S0140-6736(11)60988-4.PubMedCrossRef
2.
go back to reference Van Pottelberge GR, Bracke KR, Demedts IK, De Rijck K, Reinartz SM, van Drunen CM, Verleden GM, Vermassen FE, Joos GF, Brusselle GG: Selective accumulation of langerhans-type dendritic cells in small airways of patients with COPD. Respir Res. 2010, 11: 35-10.1186/1465-9921-11-35.PubMedPubMedCentralCrossRef Van Pottelberge GR, Bracke KR, Demedts IK, De Rijck K, Reinartz SM, van Drunen CM, Verleden GM, Vermassen FE, Joos GF, Brusselle GG: Selective accumulation of langerhans-type dendritic cells in small airways of patients with COPD. Respir Res. 2010, 11: 35-10.1186/1465-9921-11-35.PubMedPubMedCentralCrossRef
3.
go back to reference Demoor T, Bracke KR, Vermaelen KY, Dupont L, Joos GF, Brusselle GG: CCR7 modulates pulmonary and lymph node inflammatory responses in cigarette smoke-exposed mice. J Immunol. 2009, 183: 8186-8194. 10.4049/jimmunol.0902015.PubMedCrossRef Demoor T, Bracke KR, Vermaelen KY, Dupont L, Joos GF, Brusselle GG: CCR7 modulates pulmonary and lymph node inflammatory responses in cigarette smoke-exposed mice. J Immunol. 2009, 183: 8186-8194. 10.4049/jimmunol.0902015.PubMedCrossRef
4.
go back to reference Van Pottelberge GR, Bracke KR, Joos GF, Brusselle GG: The role of dendritic cells in the pathogenesis of COPD: liaison officers in the front line. COPD. 2009, 6: 284-290. 10.1080/15412550903049124.PubMedCrossRef Van Pottelberge GR, Bracke KR, Joos GF, Brusselle GG: The role of dendritic cells in the pathogenesis of COPD: liaison officers in the front line. COPD. 2009, 6: 284-290. 10.1080/15412550903049124.PubMedCrossRef
5.
go back to reference Tsoumakidou M, Demedts IK, Brusselle GG, Jeffery PK: Dendritic cells in chronic obstructive pulmonary disease: new players in an old game. Am J Respir Crit Care Med. 2008, 177: 1180-1186. 10.1164/rccm.200711-1727PP.PubMedCrossRef Tsoumakidou M, Demedts IK, Brusselle GG, Jeffery PK: Dendritic cells in chronic obstructive pulmonary disease: new players in an old game. Am J Respir Crit Care Med. 2008, 177: 1180-1186. 10.1164/rccm.200711-1727PP.PubMedCrossRef
6.
go back to reference Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, Joos GF, Brusselle GG: Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007, 175: 998-1005. 10.1164/rccm.200608-1113OC.PubMedCrossRef Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, Joos GF, Brusselle GG: Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007, 175: 998-1005. 10.1164/rccm.200608-1113OC.PubMedCrossRef
7.
go back to reference Bothelo FM, Nikota JK, Bauer CMT, Morissette MC, Iwakura Y, Kolbeck R, Finch D, Humbles AA, Stampfli MR: Cigarette-smoke induced accumulation of lung dendritic cells is interleukin-1α dependent in mice. Respir Res. 2012, 6: e28457- Bothelo FM, Nikota JK, Bauer CMT, Morissette MC, Iwakura Y, Kolbeck R, Finch D, Humbles AA, Stampfli MR: Cigarette-smoke induced accumulation of lung dendritic cells is interleukin-1α dependent in mice. Respir Res. 2012, 6: e28457-
8.
go back to reference Botelho FM, Bauer CM, Finch D, Nikota JK, Zavitz CC, Kelly A, Lambert KN, Piper S, Foster ML, Goldring JJ, et al: IL-1alpha/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One. 2011, 6: e28457-10.1371/journal.pone.0028457.PubMedPubMedCentralCrossRef Botelho FM, Bauer CM, Finch D, Nikota JK, Zavitz CC, Kelly A, Lambert KN, Piper S, Foster ML, Goldring JJ, et al: IL-1alpha/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One. 2011, 6: e28457-10.1371/journal.pone.0028457.PubMedPubMedCentralCrossRef
9.
go back to reference Chung KF: Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy. 2005, 4: 619-625. 10.2174/156801005774912806.PubMedCrossRef Chung KF: Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy. 2005, 4: 619-625. 10.2174/156801005774912806.PubMedCrossRef
10.
go back to reference Doz E, Noulin N, Boichot E, Guenon I, Fick L, Le Bert M, Lagente V, Ryffel B, Schnyder B, Quesniaux VF, Couillin I: Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol. 2008, 180: 1169-1178.PubMedCrossRef Doz E, Noulin N, Boichot E, Guenon I, Fick L, Le Bert M, Lagente V, Ryffel B, Schnyder B, Quesniaux VF, Couillin I: Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol. 2008, 180: 1169-1178.PubMedCrossRef
11.
go back to reference Bisset LR, Schmid-Grendelmeier P: Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulm Med. 2005, 11: 35-42. 10.1097/01.mcp.0000144502.50149.e0.PubMedCrossRef Bisset LR, Schmid-Grendelmeier P: Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulm Med. 2005, 11: 35-42. 10.1097/01.mcp.0000144502.50149.e0.PubMedCrossRef
12.
go back to reference Penna G, Vulcano M, Roncari A, Facchetti F, Sozzani S, Adorini L: Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol. 2002, 169: 6673-6676.PubMedCrossRef Penna G, Vulcano M, Roncari A, Facchetti F, Sozzani S, Adorini L: Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol. 2002, 169: 6673-6676.PubMedCrossRef
13.
go back to reference Demoor T, Bracke KR, Dupont LL, Plantinga M, Bondue B, Roy MO, Lannoy V, Lambrecht BN, Brusselle GG, Joos GF: The role of ChemR23 in the induction and resolution of cigarette smoke-induced inflammation. J Immunol. 2011, 186: 5457-5467. 10.4049/jimmunol.1003862.PubMedCrossRef Demoor T, Bracke KR, Dupont LL, Plantinga M, Bondue B, Roy MO, Lannoy V, Lambrecht BN, Brusselle GG, Joos GF: The role of ChemR23 in the induction and resolution of cigarette smoke-induced inflammation. J Immunol. 2011, 186: 5457-5467. 10.4049/jimmunol.1003862.PubMedCrossRef
14.
go back to reference De Swert KO, Bracke KR, Demoor T, Brusselle GG, Joos GF: Role of the tachykinin NK1 receptor in a murine model of cigarette smoke-induced pulmonary inflammation. Respir Res. 2009, 10: 37-10.1186/1465-9921-10-37.PubMedPubMedCentralCrossRef De Swert KO, Bracke KR, Demoor T, Brusselle GG, Joos GF: Role of the tachykinin NK1 receptor in a murine model of cigarette smoke-induced pulmonary inflammation. Respir Res. 2009, 10: 37-10.1186/1465-9921-10-37.PubMedPubMedCentralCrossRef
15.
go back to reference Bracke KR, D’Hulst AI, Maes T, Moerloose KB, Demedts IK, Lebecque S, Joos GF, Brusselle GG: Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol. 2006, 177: 4350-4359.PubMedCrossRef Bracke KR, D’Hulst AI, Maes T, Moerloose KB, Demedts IK, Lebecque S, Joos GF, Brusselle GG: Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol. 2006, 177: 4350-4359.PubMedCrossRef
16.
go back to reference Shan M, Yuan X, Song LZ, Roberts L, Zarinkamar N, Seryshev A, Zhang Y, Hilsenbeck S, Chang SH, Dong C, et al: Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med. 2012, 4: 117-119. Shan M, Yuan X, Song LZ, Roberts L, Zarinkamar N, Seryshev A, Zhang Y, Hilsenbeck S, Chang SH, Dong C, et al: Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med. 2012, 4: 117-119.
Metadata
Title
The dendritic cell niche in chronic obstructive pulmonary disease
Author
Angela Haczku
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2012
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-13-80

Other articles of this Issue 1/2012

Respiratory Research 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine